Phone: (414) 918-9822    Email: [email protected]

STOP-JIA (Start Time Optimization of Biologic Therapy in Polyarticular JIA) Study

 


402 PATIENTS HAVE BEEN ENROLLED
 

ENROLLMENT IS NOW CLOSED
 


 

FAMILIES WORK WITH RESEARCHERS TO FIND THE BEST WAY TO  TREAT POLYARTICULAR JIA

STOP-JIA is funded by the Patient Centered Outcomes Research Institute (PCORI).

OVERVIEW

This study compares the effectiveness of starting treatment with a non-biologic medication (such as methotrexate), a biologic medication (such as etanercept, adalimumab, and tocilizumab), or a combination of non-biologic and biologic medications for patients with polyarticular forms of Juvenile Idiopathic Arthritis (pJIA). These treatment options were standardized by CARRA pediatric rheumatologist members and published as the pJIA Consensus Treatment Plans (CTPs). The treatments are chosen through discussion between the physician, patient and family and patients are followed in the CARRA registry to see how they do.

WHO IS INVOLVED?

53 CARRA Registry sites are participating across the US and Canada.

The coordinating center is the Duke Clinical Research Institute (DCRI).

More information about the lead investigators and patient partners.

WHY THIS IS IMPORTANT

There are a number of effective biologic therapies approved for the treatment of pJIA, but we don’t know if using these treatments first line makes an important difference in how quickly the patients get better, how they do in the long-term, or is safer than starting a traditional non-biologic medicine such as methotrexate first, and only starting a biologic therapy if the traditional medicine doesn’t work. 

Our patient partners are primary members of our study team, and help us improve how the study is conducted by providing both the patient and patient perspectives. We are using electronic questionnaires to assist patients in reporting their symptoms and, for younger children, to enable parents to report their child’s symptoms.

This is the largest study to compare initial versus delayed biologic therapy in pJIA and is the first large-scale comparative effectiveness study of the CARRA pJIA CTPs.

STOP-JIA STUDY DETAILS


STOP-JIA Prezi

The STOP-JIA Prezi was created by JIA patients and parents to help people understand what STOP-JIA is all about. Please take a look and let us know what you think by leaving comments at the bottom of this page.

You may also view the Prezi as a YouTube video here.


STOP-JIA Times Newsletter

STOP-JIA Times Newsletter Issue 1
1st Issue
STOP-JIA Times Newsletter Issue 2
2nd Issue